ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs MXN
16.7395
0.04%
Brent Oil
81.18
-0.16%
Bitcoin
67,810.10
-0.17%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. BioMarin Pharmaceutical Inc (BMRN)

  7. BioMarin Pharmaceutical Inc (BMRN) Noticias

BMRN BioMarin Pharmaceutical Inc

75.90
-0.55 (-0.72%)
23 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioMarin Pharmaceutical Inc BMRN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.55 -0.72% 75.90 17:26:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
76.17 75.0319 76.17 75.90 76.45
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/5/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/5/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202416:16EDGAR2Form 8-K - Current report
13/5/202414:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202409:11EDGAR2Form 144 - Report of proposed sale of securities
09/5/202409:54EDGAR2Form 144 - Report of proposed sale of securities
08/5/202407:00PRNUSBioMarin to Present at the BofA Securities 2024 Health Care..
07/5/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/5/202415:00PRNUSNew Data for BioMarin's VOXZOGO® (vosoritide) for Multiple..
24/4/202415:03PRNUSBioMarin Reports Record Financial Results for the First..
10/4/202407:00PRNUSBioMarin to Host First Quarter 2024 Financial Results..
12/3/202407:30PRNUSNew Data to be Presented for BioMarin's VOXZOGO®..
07/3/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202407:30PRNUSBioMarin Announces Appointment of Cristin Hubbard as Chief..
06/3/202411:04EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:17EDGAR2Form 144 - Report of proposed sale of securities
05/3/202413:41EDGAR2Form 144 - Report of proposed sale of securities
05/3/202411:04EDGAR2Form 144 - Report of proposed sale of securities
01/3/202408:00PRNUSBioMarin Scheduled to Participate in March Investor..
29/2/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202409:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202412:34EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:06EDGAR2Form 8-K - Current report
22/2/202415:03PRNUSBioMarin Reports Record Financial Results for the Fourth..
12/2/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202414:24EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
12/2/202414:04EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
09/2/202416:46EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202409:36EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
BMRN
BioMarin Pharmaceutical
NASDAQ
TBNK
Territorial Bancorp
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados